Detalhe da pesquisa
1.
Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
Circ Res
; 133(8): 704-719, 2023 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698017
2.
Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models.
J Cell Mol Med
; 25(11): 4950-4961, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939252
3.
A shift from glycolytic and fatty acid derivatives toward one-carbon metabolites in the developing lung during transitions of the early postnatal period.
Am J Physiol Lung Cell Mol Physiol
; 320(4): L640-L659, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502935
4.
Influence of aminoacyl-tRNA synthetase complex-interacting multifunctional protein 1 on epithelial differentiation and organization during lung development.
Am J Physiol Lung Cell Mol Physiol
; 319(2): L369-L379, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579851
5.
A distinct transcriptional profile in response to endothelial monocyte activating polypeptide II is partially mediated by JAK-STAT3 in murine macrophages.
Am J Physiol Cell Physiol
; 317(3): C449-C456, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216192
6.
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer.
J Cell Mol Med
; 23(6): 3878-3887, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30941918
7.
α5ß1 integrin mediates pulmonary epithelial cyst formation.
Dev Dyn
; 246(6): 475-484, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370666
8.
Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.
Am J Respir Cell Mol Biol
; 55(4): 602-612, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27254784
9.
The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
J Biol Chem
; 290(15): 9753-66, 2015 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724651
10.
Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.
J Mol Cell Cardiol
; 79: 224-31, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25456857
11.
Adapted approach to profile genes while reconciling Vegf-a mRNA expression in the developing and injured lung.
Am J Physiol Lung Cell Mol Physiol
; 308(12): L1202-11, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25868151
12.
Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).
Birth Defects Res A Clin Mol Teratol
; 100(3): 180-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24619875
13.
Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension.
Cells
; 13(3)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38334636
14.
Ephrin-B2 reverse signaling increases α5ß1 integrin-mediated fibronectin deposition and reduces distal lung compliance.
Am J Respir Cell Mol Biol
; 49(4): 680-7, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23742148
15.
Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer.
Carcinogenesis
; 34(10): 2361-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23803690
16.
Establishing a peritoneal dissemination xenograft mouse model for survival outcome assessment of experimental gastric cancer.
J Surg Res
; 182(2): 227-34, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201270
17.
Enhancing gastric cancer conventional chemotherapy effects by triple angiokinase inhibitor nintedanib in preclinical models.
Front Oncol
; 13: 1145999, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37234980
18.
The efficacy of a novel, dual PI3K/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer.
J Cell Biochem
; 113(3): 784-91, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22020918
19.
Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.
Respir Res
; 13: 1, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22214516
20.
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.
Biochem Pharmacol
; 204: 115245, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36096239